2026 Hemophilia Fellowship – United States
Supports U.S. institutional fellowships to advance hemophilia care through structured education, expert mentorship, and multidisciplinary training with a focus on equity and research.
Funder: Pfizer Inc.
Due Dates: May 28, 2026 (Submission deadline)
Funding Amounts: Up to $100,000 for a one-year institutional fellowship; funds cover salary and benefits only.
Summary: Supports U.S. institutions to advance hemophilia care through education, mentorship, and multidisciplinary training for fellows.
Key Information: Applications must be submitted by 23:59 Eastern Standard Time; late submissions will not be reviewed.
Description
This competitive, institution-based fellowship grant aims to strengthen hemophilia care in the United States by supporting advanced education, mentorship, and multidisciplinary team-based training for fellows. The program focuses on equitable education, shared decision making, and addressing barriers and gaps in care, especially for underserved populations. The fellowship emphasizes structured education, expert mentorship, and a practical capstone project, with the overarching goal of advancing both clinical practice and research in hemophilia care.
